Armistice Capital, LLC Neuro Sense Therapeutics Ltd. Transaction History

Armistice Capital, LLC

  • $7.69 Billion
  • Q2 2024

A detailed history of Armistice Capital, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Armistice Capital, LLC holds 1,584,000 shares of NRSN stock, worth $2.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,584,000
Holding current value
$2.14 Million
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.84 - $2.06 $1.33 Million - $3.26 Million
1,584,000 New
1,584,000 $1.77 Million
Q3 2023

Nov 14, 2023
SELL
$0.71 - $1.47 $428,840 - $887,880
-604,000 Reduced 47.71%
662,000 $470,000
Q2 2023

Aug 14, 2023
BUY
$1.44 - $2.12 $1.82 Million - $2.68 Million
1,266,000 New
1,266,000 $1.89 Million

Others Institutions Holding NRSN

# of Institutions
8
Shares Held
1.67M
Call Options Held
0
Put Options Held
0
View Full List

About NeuroSense Therapeutics Ltd.

NRSN Quotes by TradingView
  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $15.8M
More about NRSN
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email